BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Embryo
,
Metabolism of nitric oxide
,
Fluoxetine
,
rs3825942
,
SLC12A1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cw 002
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
The future of neuromuscular blocking agents.
Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of t…
Novel neuromuscular blocking drugs and antagonists.
Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man…
Comparative pharmacodynamics of pancuronium, cisatracurium, and CW002 in rabbits.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of CW002
DEMETRA - ADVICE-002-2022
Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring …
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ